Axel Hauschild
- Oncology top 0.05%
- Molecular Biology top 0.2%
- Immunology top 0.5%
- Epidemiology top 0.5%
- Dermatology top 0.05%
- Co-authors
- Dirk SchadendorfClaus GarbeKatharina C. KählerReinhard DummerJeffrey S. WeberUlrich KeilholzJean‐Jacques GrobCarola Berking
- Topics
- Cutaneous Melanoma Detection and Management (187 papers)Melanoma and MAPK Pathways (167 papers)CAR-T cell therapy research (101 papers)
- Cited by
- OncologyDermatologyImmunology
- Partner nations
- GermanyUnited StatesFrance
In The Last Decade
Axel Hauschild
415 papers receiving 20.1k citations
Hit Papers
Peers
Comparison fields: 5 of 168
- Oncology 13.3k
- Molecular Biology 10.0k
- Immunology 4.3k
- Epidemiology 3.6k
- Dermatology 3.1k
Countries citing papers authored by Axel Hauschild
This map shows the geographic impact of Axel Hauschild's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Axel Hauschild with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Axel Hauschild more than expected).
Fields of papers citing papers by Axel Hauschild
This network shows the impact of papers produced by Axel Hauschild. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Axel Hauschild. The network helps show where Axel Hauschild may publish in the future.
Co-authorship network of co-authors of Axel Hauschild
This figure shows the co-authorship network connecting the top 25 collaborators of Axel Hauschild. A scholar is included among the top collaborators of Axel Hauschild based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Axel Hauschild. Axel Hauschild is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 2 | |
| 3 | 21 | |
| 4 | 2 | |
| 5 | 11 | |
| 6 | 47 | |
| 7 | 8 | |
| 8 | 109 | |
| 9 | 41 | |
| 10 | 8 | |
| 11 | Impact of key prognostic factors on long-term overall survival in BRAFV600-mutated metastatic melanoma patients treated with vemurafenib in the BRIM-3 study | 2 |
| 12 | 158 | |
| 13 | 154 | |
| 14 | 100 | |
| 15 | 1 | |
| 16 | 69 | |
| 17 | 167 | |
| 18 | 2 | |
| 19 | 95 | |
| 20 | 63 |
About Axel Hauschild
Axel Hauschild is a scholar working on Oncology, Dermatology and Immunology, having authored 431 papers that have together received 20.5k indexed citations. Recurring topics across this work include Cutaneous Melanoma Detection and Management (187 papers), Melanoma and MAPK Pathways (167 papers) and CAR-T cell therapy research (101 papers). The work is most often cited by research in Oncology (13.3k citations), Dermatology (3.1k citations) and Immunology (4.3k citations). Axel Hauschild has collaborated with scholars based in Germany, United States and France. Frequent co-authors include Dirk Schadendorf, Claus Garbe, Katharina C. Kähler, Reinhard Dummer, Jeffrey S. Weber, Ulrich Keilholz, Jean‐Jacques Grob, Carola Berking, Ralf Gutzmer and Selma Ugurel. Their work appears in journals such as New England Journal of Medicine, The Lancet and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.